0001794785-20-000003.txt : 20200124
0001794785-20-000003.hdr.sgml : 20200124
20200124132829
ACCESSION NUMBER: 0001794785-20-000003
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20200124
DATE AS OF CHANGE: 20200124
EFFECTIVENESS DATE: 20200124
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: AETHLON MEDICAL INC
CENTRAL INDEX KEY: 0000882291
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 133632859
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0331
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-358888
FILM NUMBER: 20544662
BUSINESS ADDRESS:
STREET 1: 9635 GRANITE RIDGE DRIVE, SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92123
BUSINESS PHONE: 858-459-7800
MAIL ADDRESS:
STREET 1: 9635 GRANITE RIDGE DRIVE, SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92123
FORMER COMPANY:
FORMER CONFORMED NAME: BISHOP EQUITIES INC
DATE OF NAME CHANGE: 19930602
D
1
primary_doc.xml
X0708
D
LIVE
0000882291
AETHLON MEDICAL INC
9635 GRANITE RIDGE DRIVE, SUITE 100
SAN DIEGO
CA
CALIFORNIA
92123
858-459-7800
NEVADA
BISHOP EQUITIES INC
Corporation
true
TIMOTHY
C.
RODELL
9635 GRANITE RIDGE DRIVE, SUITE 100
SAN DIEGO
CA
CALIFORNIA
92123
Executive Officer
Director
SABRINA
MARTUCCI JOHNSON
9635 GRANITE RIDGE DRIVE, SUITE 100
SAN DIEGO
CA
CALIFORNIA
92123
Director
EDWARD
G.
BROENNIMAN
9635 GRANITE RIDGE DRIVE, SUITE 100
SAN DIEGO
CA
CALIFORNIA
92123
Director
CHARLES
J.
FISHER
9635 GRANITE RIDGE DRIVE, SUITE 100
SAN DIEGO
CA
CALIFORNIA
92123
Director
CHETAN
S.
SHAH
9635 GRANITE RIDGE DRIVE, SUITE 100
SAN DIEGO
CA
CALIFORNIA
92123
Director
JAMES
B.
FRAKES
9635 GRANITE RIDGE DRIVE, SUITE 100
SAN DIEGO
CA
CALIFORNIA
92123
Executive Officer
GUY
CIPRIANI
9635 GRANITE RIDGE DRIVE, SUITE 100
SAN DIEGO
CA
CALIFORNIA
92123
Director
Biotechnology
Decline to Disclose
- 06b
false
2020-01-22
false
true
true
false
0
H.C. Wainwright & Co., LLC
375
None
None
430 Park Avenue, 4th Floor
New York
NY
NEW YORK
10022
IL
ILLINOIS
NY
NEW YORK
VT
VERMONT
false
2733797
2733797
0
Represents amounts receivable upon exercise of warrants to purchase common stock; such warrants have not yet been exercised.
false
7
226245
0
In addition, the placement agent was reimbursed $82,900 for expenses relating to the offering and received $37,707.56 for management fees.
0
false
AETHLON MEDICAL INC
/s/ James B. Frakes
James B. Frakes
Chief Financial Officer
2020-01-24